Department of Chemistry and Chemical Engineering, Chalmers University of Technology, GothenburgSE-412 96, Sweden.
Amferia AB, Astra Zeneca BioVentureHub c/o Astra Zeneca, Pepparedsleden 1, MölndalSE-431 83, Sweden.
ACS Appl Bio Mater. 2022 Nov 21;5(11):5289-5301. doi: 10.1021/acsabm.2c00705. Epub 2022 Nov 2.
Medical device-associated infections pose major clinical challenges that emphasize the need for improved anti-infective biomaterials. Polydimethylsiloxane (PDMS), a frequently used elastomeric biomaterial in medical devices, is inherently prone to bacterial attachment and associated infection formation. Here, PDMS surface modification strategy is presented consisting of a cross-linked lyotropic liquid crystal hydrogel microparticle coating with antibacterial functionality. The microparticle coating composed of cross-linked triblock copolymers (diacrylated Pluronic F127) was deposited on PDMS by physical immobilization via interpenetrating polymer network formation. The formed coating served as a substrate for covalent immobilization of a potent antimicrobial peptide (AMP), RRPRPRPRPWWWW-NH, yielding high contact-killing antibacterial effect against and Additionally, the coating was assessed for its ability to selectively host polar, amphiphilic, and nonpolar drugs, resulting in sustained release profiles. The results of this study put forward a versatile PDMS modification strategy for both contact-killing antibacterial surface properties and drug-delivery capabilities, offering a solution for medical device-associated infection prevention.
医疗器械相关感染是重大的临床挑战,这强调了需要改进抗感染生物材料。聚二甲基硅氧烷(PDMS)是医疗器械中常用的弹性体生物材料,其本身容易发生细菌附着和相关感染的形成。在此,提出了一种 PDMS 表面改性策略,包括具有抗菌功能的溶致液晶水凝胶微球涂层的交联。微球涂层由交联的三嵌段共聚物(二丙烯酰化 Pluronic F127)组成,通过互穿聚合物网络形成物理固定在 PDMS 上。形成的涂层作为共价固定强力抗菌肽(AMP)RRPRPRPRPWWWW-NH 的基底,对 和 表现出高接触杀菌的抗菌效果。此外,还评估了该涂层选择性容纳极性、两亲性和非极性药物的能力,导致持续释放的情况。本研究提出了一种通用的 PDMS 改性策略,兼具接触杀菌的抗菌表面性能和药物输送能力,为医疗器械相关感染的预防提供了一种解决方案。